These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 23325629)

  • 1. bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses.
    Jézéquel P; Frénel JS; Campion L; Guérin-Charbonnel C; Gouraud W; Ricolleau G; Campone M
    Database (Oxford); 2013; 2013():bas060. PubMed ID: 23325629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses.
    Jézéquel P; Gouraud W; Ben Azzouz F; Guérin-Charbonnel C; Juin PP; Lasla H; Campone M
    Database (Oxford); 2021 Feb; 2021():. PubMed ID: 33599248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer.
    Jézéquel P; Campone M; Gouraud W; Guérin-Charbonnel C; Leux C; Ricolleau G; Campion L
    Breast Cancer Res Treat; 2012 Feb; 131(3):765-75. PubMed ID: 21452023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of the bc-GenExMiner web tool in oncology].
    Jézéquel P; Gouraud W; Azzouz FB; Basseville A; Juin PP; Lasla H; Campone M
    Bull Cancer; 2021 Nov; 108(11):1057-1064. PubMed ID: 34561023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen.
    Liu R; Guo CX; Zhou HH
    Cancer Biol Ther; 2015; 16(2):317-24. PubMed ID: 25756514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome.
    Madden SF; Clarke C; Gaule P; Aherne ST; O'Donovan N; Clynes M; Crown J; Gallagher WM
    Breast Cancer Res; 2013; 15(4):R52. PubMed ID: 23820017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative Breast Cancer via Data Mining.
    Qiu Y; Lu G; Wu Y
    J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles.
    Tchou J; Kossenkov AV; Chang L; Satija C; Herlyn M; Showe LC; Puré E
    BMC Med Genomics; 2012 Sep; 5():39. PubMed ID: 22954256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer.
    Li W; Sang M; Hao X; Jia L; Wang Y; Shan B
    J Cell Biochem; 2020 Jul; 121(7):3537-3546. PubMed ID: 31886586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined analysis of gene expression, DNA copy number, and mutation profiling data to display biological process anomalies in individual breast cancers.
    Shi W; Balazs B; Györffy B; Jiang T; Symmans WF; Hatzis C; Pusztai L
    Breast Cancer Res Treat; 2014 Apr; 144(3):561-8. PubMed ID: 24619174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three-gene model to robustly identify breast cancer molecular subtypes.
    Haibe-Kains B; Desmedt C; Loi S; Culhane AC; Bontempi G; Quackenbush J; Sotiriou C
    J Natl Cancer Inst; 2012 Feb; 104(4):311-25. PubMed ID: 22262870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of key gene modules and pathways of human breast cancer cell lines.
    Wu Y; Liu F; Luo S; Yin X; He D; Liu J; Yue Z; Song J
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31285391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mining breast cancer genes with a network based noise-tolerant approach.
    Nie Y; Yu J
    BMC Syst Biol; 2013 Jun; 7():49. PubMed ID: 23799982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.
    Joseph C; Macnamara O; Craze M; Russell R; Provenzano E; Nolan CC; Diez-Rodriguez M; Sonbul SN; Aleskandarany MA; Green AR; Rakha EA; Ellis IO; Mukherjee A
    Br J Cancer; 2018 Apr; 118(8):1142-1151. PubMed ID: 29588513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
    Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
    Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlating transcriptional networks with pathological complete response following neoadjuvant chemotherapy for breast cancer.
    Liu R; Lv QL; Yu J; Hu L; Zhang LH; Cheng Y; Zhou HH
    Breast Cancer Res Treat; 2015 Jun; 151(3):607-18. PubMed ID: 25981901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy.
    Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H
    Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
    Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
    BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of key candidate genes, pathways and related prognostic values in ER-negative/HER2-negative breast cancer by bioinformatics analysis.
    Shao N; Yuan K; Zhang Y; Yun Cheang T; Li J; Lin Y
    J BUON; 2018; 23(4):891-901. PubMed ID: 30358191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.